The global longevity and anti-senescence therapies market should grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.
Report Scope:
The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023. The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which includes stem cell-based therapies, etc.
Get Sample Copy Of The Report@https://www.trendsmarketresearch.com/report/sample/11698
Revenue forecasts from 2028 to 2023 are given for each therapy and application, with estimated values derived from the expected revenue generation in the first year of launch.
The report also includes a discussion of the major players performing research or the potential players across each regional longevity and anti-senescence therapy market. Further, it explains the major drivers and regional dynamics of the global longevity and anti-senescence therapy market and current trends within the industry.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market.
Report Includes:
71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023 Country specific data and analysis for the United States, Canada, Japan, China, India, U.K., France, Germany, Spain, Australia, Middle East and Africa Detailed description of various anti-senescence therapies, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their influence in slowing down aging or reverse aging process Coverage of various therapeutic drugs, devices and technologies and information on compounds used for the development of anti-ageing therapeutics A look at the clinical trials and expected launch of anti-senescence products Detailed profiles of the market leading companies and potential entrants in the global longevity and anti-senescence therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity Biotechnology
Request For Report Discount@https://www.trendsmarketresearch.com/report/discount/11698
Summary
Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individuals lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.
Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and an increasing demand for cell-based assays in research and development.
An increasing geriatric population across the globe and a rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).
According to the National Institutes of Health (NIH), the total geriatric population across the globe in 2016 was over REDACTED. By 2022, the global geriatric population (65 years and above) is anticipated to reach over REDACTED. An increasing geriatric population across the globe will generate huge growth prospectus to the market.
Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on study of genomics, microbiome, bioinformatics and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.
Global longevity and anti-senescence market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach REDACTED, registering REDACTED in growth from REDACTED in 2018.
The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy and Others. Senolytic drug therapy held the largest market revenue share of REDACTED in 2017. By 2023, total revenue from senolytic drug therapy is expected to reach REDACTED. Gene therapy segment is estimated to rise at the highest CAGR of REDACTED till 2023. The fastest growth of the gene therapy segment is due to the Large investments in genomics. For Instance; The National Human Genome Research Institute (U.S.) had a budget grant of REDACTED for REDACTED research projects in 2015, thus increasing funding to REDACTED for approximately REDACTED projects in 2016.
Report Analysis@https://www.trendsmarketresearch.com/report/analysis/BCC/global-longevity-and-anti-senescence-therapy-market
See the rest here:
Longevity And Anti-Senescence Therapy Market Overview, Consumption, Supply, Demand & Insights - Kentucky Journal 24
- Blood cancer awareness month: learn to recognize the signs and symptoms - Commonwealth Journal's History - September 25th, 2022
- University of Kentucky Equine Research Hall of Fame announces awardees - DVM 360 - September 25th, 2022
- U.S. States With The Highest Cancer Rates - WorldAtlas - August 14th, 2022
- Robin Turner and James Piret Receive 2022 William F. Meggers Award - Spectroscopy Online - August 14th, 2022
- Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress - Kentucky Today - June 13th, 2022
- College of Education professor takes Covid-19 research to Kentucky schools - WUKY - June 4th, 2022
- UV Radiation and the Skin - PubMed Central (PMC) - January 20th, 2022
- Give the Gift of Life During the Evan's Journey Blood Drive with the Red Cross January 21st - wkdq.com - January 5th, 2022
- Top 10 stories of 2021 - The Tribune | The Tribune - Ironton Tribune - January 5th, 2022
- It's time for Kentucky to talk to expectant parents about benefits of cord blood banking - Courier Journal - November 11th, 2020
- Does Talaris' Investigational Cell Therapy Have Potential to Be a 'Pipeline in a Product'? - BioSpace - November 11th, 2020
- Commentary: Kentucky's research universities UK and UofL answering the call now and for the future - User-generated content - May 24th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 30th, 2020
- The One Crucial Step Gov. Cuomo Hasn't Taken That Could Save Thousands Of Lives - HuffPost - April 19th, 2020
- The Pro-Life Movement Youve Never Heard Of - National Review - March 20th, 2020
- About Us | Stem Cell Therapy | Stem Cell Treatment ... - September 12th, 2019
- Stem Cell Therapy | Stem Cell Therapy | Stem Cell ... - September 10th, 2019
- Equine Stem Cell Therapy: The Future of Tendon Treatment ... - May 12th, 2019
- Stem Cell Louisville Kentucky 40217 - April 20th, 2019
- Adult Stem Cell Success Story | Kidney Disease | SCRF - March 31st, 2019
- Stem Cell Ashland Kentucky 41101 - March 1st, 2019
- Stem Cell Therapy Kentucky Neurology and Rehab - August 23rd, 2018
- Why Stem Cell Therapy for Pets? | MediVet Biologics - July 23rd, 2018
- Case Western Reserve University Researchers Develop Therapeutic to Enhance Tissue Repair and Regeneration - Newswise (press release) - August 8th, 2017
- Cancer survivor meets bone marrow donor days before wedding - WBNG-TV - August 8th, 2017
- McConnell: Action needed on health insurance - Richmond Register - July 9th, 2017
- Santa Monica's NASA Astronaut Randy Bresnik Live Interviews Before Space Station Mission - Santa monica Observed - July 9th, 2017
- Cloning - Wikipedia - December 7th, 2016
- The ALS Association - November 23rd, 2016
- Stem Cell Research | Central Kentucky Right to Life - November 20th, 2016
- Division of Cardiovascular Medicine School of Medicine ... - November 20th, 2016
- Louisville Man is Worlds First Cardiac Stem Cell Recipient - October 28th, 2016
- Cord Blood - Louisville, Kentucky(KY), Cord Blood Storage ... - September 8th, 2016
- Bone Marrow Transplant - Louisville, Kentucky(KY), Stem ... - September 6th, 2016
- The leukemic stem cell - PubMed Central (PMC) - August 22nd, 2016
- Can Stem Cells Really Repair Regenerate Cartilage Injuries ... - August 19th, 2016
- Rob Waddell Defeats Kidney Disease - Adult Stem Cells - July 25th, 2016
- DNC NEWS: Feverfew, Stem cells and the treatment of Cancer - October 19th, 2015
- Gill Heart Institute Researcher Explores Stem Cell Therapy ... - July 2nd, 2015
- Tag louisville Archives - Advance Stem Cell ... - June 7th, 2015
- WKU plans bone marrow registry drive - April 7th, 2015
- Research Programs at Universities and Institutions [Stem ... - March 14th, 2015
- Stem Cell Therapy for Diabetes - YouTube - March 1st, 2015
- Medivet Biologics launches newest service, K9-ACV a personalized medicine approach to canine cancer. - January 17th, 2015
- Frontiers in Stem Cells & Regeneration - Marine Biological ... - January 10th, 2015
- Good News: Large Majorities Support Embryonic Stem Cell ... - December 27th, 2014
- How to Invest in Stem Cell Companies | eHow - December 3rd, 2014
- HIV drugs show promise in treating common eye disease - November 23rd, 2014
- 117.69 /$ (12 a.m.) - November 23rd, 2014
- Mesenchymal Stem Cells | National Stem Cell Foundation - October 27th, 2014
- Stem Cell Therapy KY - Be Medispa - October 15th, 2014
- How Do Stem Cells Differentiate? | eHow - September 27th, 2014
- Stem Cell Laboratory - Rood and Riddle - September 27th, 2014
- Worlds first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction - September 20th, 2014
- Stem Cell Scandal - August 30th, 2014
- STEM CELL SUCCESS STORIES Archives ... - August 23rd, 2014
- Genetic Disease Stem Cell Research, MS Treatments ... - August 23rd, 2014
- Kentucky Stem Cell Treatment and therapy | Stem Cell ... - August 22nd, 2014
- Kentucky Stem Cell Treatment | Stem Cell Treatments - August 22nd, 2014